Home/Filings/4/0001181431-13-063798
4//SEC Filing

ACHILLION PHARMACEUTICALS INC 4

Accession 0001181431-13-063798

CIK 0001070336operating

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 5:10 PM ET

Size

5.2 KB

Accession

0001181431-13-063798

Insider Transaction Report

Form 4
Period: 2013-12-17
Apelian David
EVP and Chief Medical Officer
Transactions
  • Award

    Employee Stock Option(Right to Buy)

    2013-12-17300,000300,000 total
    Exercise: $3.02Exp: 2023-12-17Common Stock (300,000 underlying)
Footnotes (1)
  • [F1]This option grant vests as to 25% of the shares on the first anniversary of the date of grant and as to an additional 6.25% at the end of each three month period thereafter.

Issuer

ACHILLION PHARMACEUTICALS INC

CIK 0001070336

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001070336

Filing Metadata

Form type
4
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 5:10 PM ET
Size
5.2 KB